Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (605)	8/5/2004 9:32:48 PM
From: Henrik	Respond to of 3722

Thank you for your analysis Bernard. (EOM)

To: Jibacoa who wrote (605)	10/13/2004 8:37:18 PM
From: Henrik	Read Replies (1) \| Respond to of 3722

Progen (PGLAF) - Bernard, back in early August you did a comprehensive (TA) analysis of PGLAF. Since then the stock has gone even further with rate of knots. No real news released. A pending deal with a pharma is the speculation in the street at the moment. Major players – institutions - are joining in after Progen was included in the ASX/S&P300 index in Australia late September. I wonder if you can see any overhead resistance as it makes new multi year highs. Your input is appreciated. Best regards, Henrik stockcharts.com[h,a]daclyiay[pb20!b10!f][vc60][iut!Ub4!Ua12,26,9]&pref=G